HomeInsights52 Week High Stocks

Mankind Pharma Ltd 52 Week High

Mankind Pharma Ltd 52 Week High

stocks purchased

₹ 4.4 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

15.5 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Mankind Pharma Ltd

NSE: MANKIND

YEARHIGH

₹ 2920.05

Last updated on: Dec 20, 2024

Key Highlights

  • The 52 Week HIGH of Mankind Pharma Ltd is ₹ 2920 as of 20 Dec 24 .

Company Fundamentals for Mankind Pharma Ltd

No data available

Market Price of Mankind Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Mankind Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20242803.45
19 Dec 20242889.45
18 Dec 20242805.55
17 Dec 20242661.2
16 Dec 20242690.8
13 Dec 20242640.3
12 Dec 20242650.55
11 Dec 20242623.1
10 Dec 20242668.75
09 Dec 20242640.05

Asset Value vs Market Value of Mankind Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Mankind Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Mankind Pharma Ltd

No data available

* All values are in crore

Mankind Pharma Ltd News Hub

News

Mankind Pharma allots 1.19 cr equity shares under QIP issue

Mankind Pharma has allotted 1,19,04,761 equity shares of face value of Re 1 each to the el...

Read more

20 Dec 2024 14:17

News

Mankind Pharma raises nearly Rs 3,000 crore from eligible institutional buyers via QIP issue

The company has approved the allocation of 1,19,04,761 equity shares at an issue price of ...

Read more

20 Dec 2024 11:52

News

Mankind Pharma edges higher after board approves opening of Rs 3,000 crore QIP issue

The company's board authorized and declared the opening of the issue on Monday, 16 Decembe...

Read more

17 Dec 2024 10:07

News

Mankind Pharma Ltd rises for third consecutive session

Mankind Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 2...

Read more

02 Dec 2024 13:05

News

Mankind Pharma Ltd slips for fifth straight session

Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs ...

Read more

13 Nov 2024 13:14

News

Mankind Pharma receives reaffirmation in credit rating from CRISIL

Mankind Pharma has received reaffirmation in credit ratings from CRISIL as under: Commerci...

Read more

06 Nov 2024 13:15

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Mankind Pharma Ltd

What is the significance of Mankind Pharma Ltd reaching its 52-week high?

Mankind Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Mankind Pharma Ltd 52-week high?

Investors monitor Mankind Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Mankind Pharma Ltd a good buy when it hits its 52-week high?

Whether Mankind Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Mankind Pharma Ltd fundamentals.

What should I consider before investing in Mankind Pharma Ltd at its 52-week high?

Before investing in Mankind Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Mankind Pharma Ltd stock price continue to rise after reaching its 52-week high?

Mankind Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions